Search research articles
Contact Us
Filters
Showing results (51-60 of 107) with videos related to
Page
of 11
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 14, 2025
Trabectedin maintenance therapy after liposomal doxorubicin plus trabectedin combination in patients with relapsed ovarian cancer: the randomized, phase II TRAMANT study
Giuseppa Scandurra, Giuseppe Scibilia, Valentina Lombardo, et al.
Tumori
|
October 27, 2020
Management of ovarian cancer: guidelines of the Italian Medical Oncology Association (AIOM)
Angiolo Gadducci, Giovanni D Aletti, Fabio Landoni, et al.
Minerva Ginecologica
|
June 10, 2017
Early detection of recurrence or progression disease in patients with ovarian cancer after primary debulking surgery. Correlation between CT findings and CA 125 levels
Michela Giuliani, Benedetta Gui, Anna L Valentini, et al.
Annals of Surgical Oncology
|
December 15, 2023
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor: A Single-Institution Experience (ID: PARROT Trial)
Giuseppe Vizzielli, Maria Teresa Giudice, Federica Nardelli, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
April 16, 2022
Needleoscopic-assisted risk-reducing bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers: Peri-operative outcomes and psychological impact
Andrea Rosati, Camilla Fedele, Anna Fagotti, et al.
Frontiers in Oncology
|
March 14, 2022
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives
Lucia Musacchio, Carlo Maria Cicala, Vanda Salutari, et al.
Critical Reviews in Oncology/Hematology
|
October 18, 2022
Advanced and recurrent endometrial cancer: State of the art and future perspectives
Francesca Tronconi, Camilla Nero, Elena Giudice, et al.
Cancer Management and Research
|
October 4, 2023
Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data
Veronica Agostinelli, Lucia Musacchio, Floriana Camarda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 21, 2024
Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18)
Anna Fagotti, Barbara Costantini, Francesco Fanfani, et al.
Cancer Treatment Reviews
|
September 5, 2022
MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysis
Lucia Musacchio, Anna Amela Valsecchi, Vanda Salutari, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 107) with videos related to
Sort By:
Page
of 11
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 14, 2025
Trabectedin maintenance therapy after liposomal doxorubicin plus trabectedin combination in patients with relapsed ovarian cancer: the randomized, phase II TRAMANT study
Giuseppa Scandurra, Giuseppe Scibilia, Valentina Lombardo, et al.
Tumori
|
October 27, 2020
Management of ovarian cancer: guidelines of the Italian Medical Oncology Association (AIOM)
Angiolo Gadducci, Giovanni D Aletti, Fabio Landoni, et al.
Minerva Ginecologica
|
June 10, 2017
Early detection of recurrence or progression disease in patients with ovarian cancer after primary debulking surgery. Correlation between CT findings and CA 125 levels
Michela Giuliani, Benedetta Gui, Anna L Valentini, et al.
Annals of Surgical Oncology
|
December 15, 2023
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor: A Single-Institution Experience (ID: PARROT Trial)
Giuseppe Vizzielli, Maria Teresa Giudice, Federica Nardelli, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
April 16, 2022
Needleoscopic-assisted risk-reducing bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers: Peri-operative outcomes and psychological impact
Andrea Rosati, Camilla Fedele, Anna Fagotti, et al.
Frontiers in Oncology
|
March 14, 2022
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives
Lucia Musacchio, Carlo Maria Cicala, Vanda Salutari, et al.
Critical Reviews in Oncology/Hematology
|
October 18, 2022
Advanced and recurrent endometrial cancer: State of the art and future perspectives
Francesca Tronconi, Camilla Nero, Elena Giudice, et al.
Cancer Management and Research
|
October 4, 2023
Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data
Veronica Agostinelli, Lucia Musacchio, Floriana Camarda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 21, 2024
Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18)
Anna Fagotti, Barbara Costantini, Francesco Fanfani, et al.
Cancer Treatment Reviews
|
September 5, 2022
MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysis
Lucia Musacchio, Anna Amela Valsecchi, Vanda Salutari, et al.
Page
of 11